Works matching DE "GLUCAGON receptors"

Results: 230
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Hypoglycemia and Alzheimer Disease Risk: The Possible Role of Dasiglucagon.

    Published in:
    Cellular & Molecular Neurobiology, 2024, v. 44, n. 1, p. 1, doi. 10.1007/s10571-024-01489-y
    By:
    • Ali, Naif H.;
    • Al-Kuraishy, Hayder M.;
    • Al-Gareeb, Ali I.;
    • Hadi, Najah R.;
    • Assiri, Abdullah A.;
    • Alrouji, Mohammed;
    • Welson, Nermeen N.;
    • Alexiou, Athanasios;
    • Papadakis, Marios;
    • Batiha, Gaber El-Saber
    Publication type:
    Article
    19
    20
    21

    Arginine- vasopressin mediates counterregulatory glucagon release and is diminished in type 1 diabetes.

    Published in:
    eLife, 2021, p. 1, doi. 10.7554/eLife.72919
    By:
    • Kim, Angela;
    • Knudsen, Jakob G.;
    • Madara, Joseph C.;
    • Benrick, Anna;
    • Hill, Thomas G.;
    • Kadir, Lina Abdul;
    • Kellard, Joely A.;
    • Mellander, Lisa;
    • Miranda, Caroline;
    • Haopeng Lin;
    • James, Timothy;
    • Suba, Kinga;
    • Spigelman, Aliya F.;
    • Yanling Wu;
    • MacDonald, Patrick E.;
    • Asterholm, Ingrid Wernstedt;
    • Magnussen, Tore;
    • Christensen, Mikkel;
    • Vilsbøll, Tina;
    • Salem, Victoria
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Safety, pharmacokinetics and pharmacodynamics of HRS‐7535, a novel oral small molecule glucagon‐like peptide‐1 receptor agonist, in healthy participants: A phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose, and food effect trial

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 3, p. 901, doi. 10.1111/dom.15383
    By:
    • Wu, Jingying;
    • Zhou, Renpeng;
    • Zhang, Qian;
    • Zhang, Qin;
    • Qin, Huiling;
    • Ye, Zi;
    • Xu, Yimei;
    • Feng, Sheng;
    • Shu, Chang;
    • Shen, Yu;
    • Fan, Yang;
    • Wang, Quanren;
    • Du, Yijun;
    • Hu, Wei
    Publication type:
    Article
    34

    Comparison of clinical efficacy and safety of weekly glucagon‐like peptide‐1 receptor agonists dulaglutide and semaglutide in Japanese patients with type 2 diabetes: Randomized, parallel‐group, multicentre, open‐label trial (COMING study)

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 12, p. 3632, doi. 10.1111/dom.15258
    By:
    • Kimura, Tomohiko;
    • Katakura, Yukino;
    • Shimoda, Masashi;
    • Kawasaki, Fumiko;
    • Yamabe, Mizuho;
    • Tatsumi, Fuminori;
    • Matsuki, Michihiro;
    • Iwamoto, Yuichiro;
    • Anno, Takatoshi;
    • Fushimi, Yoshiro;
    • Kamei, Shinji;
    • Kimura, Yukiko;
    • Nakanishi, Shuhei;
    • Mune, Tomoatsu;
    • Kaku, Kohei;
    • Kaneto, Hideaki
    Publication type:
    Article
    35
    36
    37
    38
    39

    Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of SOUL, a randomized trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 7, p. 1932, doi. 10.1111/dom.15058
    By:
    • McGuire, Darren K.;
    • Busui, Rodica P.;
    • Deanfield, John;
    • Inzucchi, Silvio E.;
    • Mann, Johannes F. E.;
    • Marx, Nikolaus;
    • Mulvagh, Sharon L.;
    • Poulter, Neil;
    • Engelmann, Mads D. M.;
    • Hovingh, G. Kees;
    • Ripa, Maria Sejersten;
    • Gislum, Mette;
    • Brown‐Frandsen, Kirstine;
    • Buse, John B.
    Publication type:
    Article
    40
    41
    42
    43
    44

    Glucagon induces the hepatic expression of inflammatory markers in vitro and in vivo.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 556, doi. 10.1111/dom.14902
    By:
    • Andreozzi, Francesco;
    • Di Fatta, Concetta;
    • Spiga, Rosangela;
    • Mannino, Gaia Chiara;
    • Mancuso, Elettra;
    • Averta, Carolina;
    • De Caro, Carmen;
    • Tallarico, Martina;
    • Leo, Antonio;
    • Citraro, Rita;
    • Russo, Emilio;
    • De Sarro, Giovambattista;
    • Sesti, Giorgio
    Publication type:
    Article
    45
    46

    Acute concomitant glucose‐dependent insulinotropic polypeptide receptor antagonism during glucagon‐like peptide 1 receptor agonism does not affect appetite, resting energy expenditure or food intake in patients with type 2 diabetes and overweight/obesity

    Published in:
    Diabetes, Obesity & Metabolism, 2022, v. 24, n. 9, p. 1882, doi. 10.1111/dom.14736
    By:
    • Stensen, Signe;
    • Krogh, Liva L.;
    • Sparre‐Ulrich, Alexander H.;
    • Dela, Flemming;
    • Hartmann, Bolette;
    • Vilsbøll, Tina;
    • Holst, Jens J.;
    • Rosenkilde, Mette M.;
    • Christensen, Mikkel B.;
    • Gasbjerg, Lærke S.;
    • Knop, Filip K.
    Publication type:
    Article
    47
    48
    49
    50